Cargando…

T cells in myositis

T cells of both the CD4 and CD8 lineage are commonly found in affected tissues of patients with idiopathic inflammatory myopathies, but understanding the contribution of these cells to immunopathogenesis remains challenging. Given recent advances in identifying more myositis-associated autoantibodie...

Descripción completa

Detalles Bibliográficos
Autores principales: Malmström, Vivianne, Venalis, Paulius, Albrecht, Inka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674618/
https://www.ncbi.nlm.nih.gov/pubmed/23270751
http://dx.doi.org/10.1186/ar4116
_version_ 1782272392921350144
author Malmström, Vivianne
Venalis, Paulius
Albrecht, Inka
author_facet Malmström, Vivianne
Venalis, Paulius
Albrecht, Inka
author_sort Malmström, Vivianne
collection PubMed
description T cells of both the CD4 and CD8 lineage are commonly found in affected tissues of patients with idiopathic inflammatory myopathies, but understanding the contribution of these cells to immunopathogenesis remains challenging. Given recent advances in identifying more myositis-associated autoantibodies and their putative targets, we suggest that studies on autoreactive T cells targeting those autoantigens are one way forward. Another (so far, more frequently used) approach comes from studies on effector T cells in the context of myositis. This review summarizes recent advances and current hypotheses in both of these contexts.
format Online
Article
Text
id pubmed-3674618
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36746182013-06-28 T cells in myositis Malmström, Vivianne Venalis, Paulius Albrecht, Inka Arthritis Res Ther Review T cells of both the CD4 and CD8 lineage are commonly found in affected tissues of patients with idiopathic inflammatory myopathies, but understanding the contribution of these cells to immunopathogenesis remains challenging. Given recent advances in identifying more myositis-associated autoantibodies and their putative targets, we suggest that studies on autoreactive T cells targeting those autoantigens are one way forward. Another (so far, more frequently used) approach comes from studies on effector T cells in the context of myositis. This review summarizes recent advances and current hypotheses in both of these contexts. BioMed Central 2012 2012-12-28 /pmc/articles/PMC3674618/ /pubmed/23270751 http://dx.doi.org/10.1186/ar4116 Text en Copyright ©2012 BioMed Central Ltd
spellingShingle Review
Malmström, Vivianne
Venalis, Paulius
Albrecht, Inka
T cells in myositis
title T cells in myositis
title_full T cells in myositis
title_fullStr T cells in myositis
title_full_unstemmed T cells in myositis
title_short T cells in myositis
title_sort t cells in myositis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674618/
https://www.ncbi.nlm.nih.gov/pubmed/23270751
http://dx.doi.org/10.1186/ar4116
work_keys_str_mv AT malmstromvivianne tcellsinmyositis
AT venalispaulius tcellsinmyositis
AT albrechtinka tcellsinmyositis